Skip to main content

Table 2 Behavioral measures for Study 2 comparing participants from lorazepam, placebo, and yohimbine groups

From: An elevated plus-maze in mixed reality for studying human anxiety-related behavior

Measures Lorazepam Placebo Yohimbine
Mean ± SE Min Max Mean ± SE Min Max Mean ± SE Min Max
Latency open arm exploration (s) 42.1 9.5 5.3 113.8 92.9 25.8 9.8 300 148.9 34.4 4.2 300
Latency open arm end exploration (s) 133.6 26.6 15.5 300 177.1 28.7 17.6 300 193.4 31.7 11.5 300
Time on open arms (s) 131.3 9.6 52.8 187.4 97.8 15.5 0 195.0 58.1 14.6 0 146.7
Time on open arms (%) 43.8 3.2 17.6 62.5 32.6 5.2 0 65.0 19.4 4.9 0 48.9
Time on closed arms (s) 46.1 5.6 10.8 105.3 39.1 9.5 0 165.3 53.3 15.4 0 218.2
Time in center (s) 122.1 9.7 77.0 207.8 162.4 18.4 79.4 300 187.9 19.5 81.1 300
Time in center and on closed arms (s) 168.2 9.5 111.9 246.4 201.6 15.6 104.2 300 241.2 15.6 152.6 300
Time in immobility (s) 198.2 8.4 131.6 269.5 205.7 15.7 86.0 300 219.4 13.2 114.6 290.8
Average velocity on open arms (m/s) 0.044 0.004 0.019 0.083 0.040 0.007 0 0.099 0.032 0.007 0 0.081
Average velocity on closed arms (m/s) 0.074 0.006 0.032 0.129 0.070 0.012 0 0.148 0.061 0.011 0 0.139
Total distance covered (m) 13.6 1.0 6.5 25.1 12.6 1.8 0 27.9 11.1 1.4 3.8 22.9
Number of entries open arms (n) 4.4 0.6 0 11 4.3 0.8 0 10 2.9 0.7 0 9
Number of entries closed arms (n) 2.9 0.3 1 6 2.4 0.4 0 5 2.1 0.4 0 5
  1. Measures are given as mean ± SE
  2. SE standard error, Min minimum, Max maximum values